Le Lézard
Classified in: Health, Covid-19 virus
Subject: PDT

Rexall®, IDA®, Guardian®, Remedy's Rx® and The Medicine Shoppe® to Provide Safe and Convenient Access to COVID-19 Testing in Select Locations Across Ontario


McKesson Canada supports Government of Ontario decision to allow COVID-19 testing in pharmacies

MISSISSAUGA, ON, Sept. 23, 2020 /CNW Telbec/ - As the fight against COVID-19 continues, select Rexall and McKesson Canada's Retail Banner Group (Guardian®, IDA®, the Medicine Shoppe®, Remedy's Rx®) Ontario pharmacies will begin providing COVID-19 testing for asymptomatic individuals. In order to protect the health and safety of customers, patients and employees, COVID-19 testing within pharmacies must be made through appointment only.

"Pharmacists are increasingly taking on expanded roles in the Canadian healthcare system, while being recognized as essential partners in care delivery," said Rebecca McKillican, CEO, McKesson Canada. "We welcome today's news from the Government of Ontario, instilling confidence in our pharmacists as they continually step up on the frontlines to stop the spread of COVID-19 in our communities."

McKesson Canada is currently supporting COVID-19 testing for asymptomatic patients in Alberta, where IDA®, Guardian®, Remedy's Rx®, the Medicine Shoppe® and Rexall® pharmacies were early adopters as part of the province's original pilot program. McKesson Canada's network of participating pharmacies have conducted thousands of tests to date, and will use the training, tools, and supports developed to ensure best practices are implemented in Ontario.  

"Community pharmacists are proud to be supporting the province's efforts in the fight against COVID-19," continued McKillican. "Increasing the availability of testing is an important step to protect families, loved ones, and the people we encounter on a daily basis."

COVID-19 testing increases Ontario's ability to determine the prevalence of the infection across the province's population and to understand the spread and presence of COVID-19. For more information on which locations offer COVID-19 testing to asymptomatic patients, please visit
https://news.ontario.ca/en/release/58492/ontario-expands-covid-19-testing-to-pharmacies.

About McKesson Canada
Founded more than 100 years ago, McKesson Canada is dedicated to delivering vital medicines, supplies and information technologies that enable the healthcare industry to provide patients better, safer care. Our solutions empower pharmacies, manufacturers, hospitals and other healthcare institutions by enabling them to get closer to the millions of patients they serve every single day, while contributing to the quality and safety of care in Canada. For more information, please visit mckesson.ca.

SOURCE MCKESSON CANADA


These press releases may also interest you

at 15:00
Cornerstone Community Bancorp announced today its financial results for the first quarter ended March 31, 2024. The Company reported net income of $1,394,000 for the three months ended March 31, 2024 compared to net income of $1,695,000 for the...

at 12:20
The "Global Influencer Marketing Platform Market: Analysis By Component, By Application, By Organization Size, By End Use, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 11:55
The "COVID-19 Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global COVID-19 Vaccines Market to Reach 4.2 Billion Doses by 2025 The global market for COVID-19 Vaccines, estimated at 6.4 Billion...

at 10:55
As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the...

at 10:30
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

at 10:25
The "Global High-Altitude Aeronautical Platform Station (HAAPS) Market: Focus on Type, Frequency Band, Subsystem, Application, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The...



News published on and distributed by: